The objective of this study was to evaluate the expression of neutrophil activation markers CD11b and CD66b, together with the spontaneous NET release on T2DM patients in different stages of DR to analyze the association of these inflammatory markers with hyperglycemia and renal failure and to elucidate whether these inflammatory markers are associated with DR development. Here, ITGAM is linked to type 2 diabetes mellitus.